Genetic Risk Factors in Japanese Alzheimer’s Disease Patients: α1-ACT, VLDLR, and ApoE
- 28 February 1998
- journal article
- Published by Elsevier in Neurobiology of Aging
- Vol. 19 (1), S43-S46
- https://doi.org/10.1016/s0197-4580(98)00035-9
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Lack of association of very low density lipoprotein receptor gene polymorphism with caucasian Alzheimer's diseaseAnnals of Neurology, 1996
- Lack of association of trinucleotide repeat polymorphisms in the very‐low‐density lipoprotein receptor gene with Alzhelner's diseaseAnnals of Neurology, 1996
- No Genetic Effect of α1-Antichymotrypsin in Alzheimer DiseaseGenomics, 1996
- Genetic association of the very low density lipoprotein (VLDL) receptor gene with sporadic Alzheimer's diseaseNature Genetics, 1995
- A4POE*4-associated Alzheimer's disease risk is modified by α1–antichymotrypsin polymorphismNature Genetics, 1995
- Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's diseaseNature, 1995
- CGG triple repeat polymorphism in VLDL receptor (VLDL-R) geneHuman Molecular Genetics, 1994
- Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset FamiliesScience, 1993
- Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's diseaseNature, 1991
- Clinical diagnosis of Alzheimer's diseaseNeurology, 1984